XALKORI
XALKORI
Approved
DIN Number
02384264
Drug Class
Human
Market Date
May 10, 2012
Company
HC
Pfizer Canada Ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02384264
AIG Number0153140002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01ED01 CRIZOTINIB
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
CRIZOTINIBActive
Strength: 250 MG
Monograph: CRIZOTINIB